235 results
Page 3 of 12
8-K
c2i2ds
4 Oct 21
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.1
z23 pz4uir4civu5j
5 Aug 21
Unaudited Pro Forma Consolidated Financial Statements of Adamis Pharmaceuticals Corporation
5:07pm
PREC14A
7t3lcs5f b93zy
23 Jun 21
Preliminary proxy with contested solicitation
4:17pm
DEFC14A
rxgdu5olzwclczp
14 Jun 21
Proxy in contested solicitation
6:01am
PREC14A
mx41a97xlywtmw8
1 Jun 21
Preliminary proxy with contested solicitation
10:06am
424B5
648hmgzwr
29 Jan 21
Prospectus supplement for primary offering
5:15pm
8-K
EX-1.1
aocjcrd 1fd8w9njmf0
29 Jan 21
Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock
5:10pm
424B5
yg25phk dd
28 Jan 21
Prospectus supplement for primary offering
4:08pm
8-K
EX-99.1
yi0m4a3r136gx
5 Oct 20
Report of Independent Registered Public Accounting Firm
5:25pm
424B5
wuo0mgv9l4iki0loa995
21 Sep 20
Prospectus supplement for primary offering
6:03am
8-K
EX-1.1
a9vrkjbhj9gmm3w4
18 Sep 20
Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:53pm
424B5
axr9gyh63xdb
17 Sep 20
Prospectus supplement for primary offering
4:22pm
8-K
EX-99.1
ff4anp8e51x
18 Aug 20
Adamis Pharmaceuticals Announces Second Quarter 2020 Financial Results and Business Update
12:00am